Live feed
Filing
SC 13D/A
SC 13D/A0000078003-23-000104·Allogene Therapeutics, Inc.
Schedule 13D ownership disclosure
Allogene Therapeutics Inc
Security class unavailable · CUSIP: 019770106
Event date: 2023-08-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,032,040
- Percent of class
- 13.1400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-23-000104
- Form type
- SC 13D/A
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Oct 25, 2023
- Reporting period
- Aug 02, 2023
- Description
- Schedule 13D beneficial ownership